187 related articles for article (PubMed ID: 9213214)
21. Influence of calcium channel blocker treatment on the mechanical properties of diabetic rat myocardium.
Brown RA; Lee MM; Sundareson AM; Woodbury DJ; Savage AO
Acta Diabetol; 1996 Mar; 33(1):7-14. PubMed ID: 8777289
[TBL] [Abstract][Full Text] [Related]
22. Effects of mibefradil, a blocker of T-type Ca2+ channels, in single myocytes and intact muscle of guinea-pig heart.
Emanuel K; Mackiewicz U; Pytkowski B; Lewartowski B
J Physiol Pharmacol; 1998 Dec; 49(4):577-90. PubMed ID: 10069698
[TBL] [Abstract][Full Text] [Related]
23. Proliferation of human peripheral blood mononuclear cells during calcium channel blockade.
Lijnen P; Fagard R; Petrov V
Am J Hypertens; 1998 Dec; 11(12):1461-8. PubMed ID: 9880128
[TBL] [Abstract][Full Text] [Related]
24. Comparative effects of mibefradil and other calcium antagonists on resistance arteries of different end organs.
van der Lee R; Pfaffendorf M; van Zwieten PA
Fundam Clin Pharmacol; 1999; 13(2):198-203. PubMed ID: 10226764
[TBL] [Abstract][Full Text] [Related]
25. Differential antagonism by Bay k 8644, a dihydropyridine calcium agonist, of the negative inotropic effects of nifedipine, verapamil, diltiazem and manganese ions in canine ventricular muscle.
Ishii K; Taira N; Yanagisawa T
Br J Pharmacol; 1985 Feb; 84(2):577-84. PubMed ID: 2579702
[TBL] [Abstract][Full Text] [Related]
26. Ro 40-5967, a novel calcium channel antagonist, protects against ventricular fibrillation.
Billman GE
Eur J Pharmacol; 1992 Dec; 229(2-3):179-87. PubMed ID: 1490522
[TBL] [Abstract][Full Text] [Related]
27. Negative inotropic effect of verapamil, nifedipine and prenylamine and its reversal by calcium or isoproterenol.
Mattiazzi AR; Garay A
Arch Int Physiol Biochim; 1983 Sep; 91(3):133-44. PubMed ID: 6198983
[TBL] [Abstract][Full Text] [Related]
28. Effects of Ca2+ channel blockers on Ca2+ loading induced by metabolic inhibition and hyperkalemia in cardiomyocytes.
Tang T; Duffield R; Ho AK
Eur J Pharmacol; 1998 Nov; 360(2-3):205-11. PubMed ID: 9851587
[TBL] [Abstract][Full Text] [Related]
29. Mibefradil-induced inhibition of proliferation of human peripheral blood mononuclear cells.
Lijnen P; Fagard R; Petrov V
J Cardiovasc Pharmacol; 1999 Apr; 33(4):595-604. PubMed ID: 10218730
[TBL] [Abstract][Full Text] [Related]
30. Unique cardioprotective action of the new calcium antagonist mibefradil.
Schulz R; Post H; Jalowy A; Backenköhler U; Dörge H; Vahlhaus C; Heusch G
Circulation; 1999 Jan; 99(2):305-11. PubMed ID: 9892599
[TBL] [Abstract][Full Text] [Related]
31. Ro 40-5967, in contrast to diltiazem, does not reduce left ventricular contractility in rats with chronic myocardial infarction.
Véniant M; Clozel JP; Hess P; Wolfgang R
J Cardiovasc Pharmacol; 1991 Feb; 17(2):277-84. PubMed ID: 1709233
[TBL] [Abstract][Full Text] [Related]
32. Mibefradil, A T-type calcium channel antagonist in Y1 cells.
Esneu M; Gallo-Payet N; Payet MD
Endocr Res; 1998; 24(3-4):449-54. PubMed ID: 9888524
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of chronic calcium channel blocker treatment on the inotropic response of diabetic rat myocardium to acute ethanol exposure.
Brown RA; Sundareson AM; Lee MM; Savage AO
Life Sci; 1996; 59(10):835-47. PubMed ID: 8761317
[TBL] [Abstract][Full Text] [Related]
34. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of signal Ca2+ in dog coronary arterial vascular muscle cells by Ro 40-5967.
Mishra SK; Hermsmeyer K
J Cardiovasc Pharmacol; 1994 Jul; 24(1):1-7. PubMed ID: 8078332
[TBL] [Abstract][Full Text] [Related]
36. Mibefradil improves beta-adrenergic responsiveness and intracellular Ca(2+) handling in hypertrophied rat myocardium.
Min JY; Meissner A; Wang J; Morgan JP
Exp Biol Med (Maywood); 2002 May; 227(5):336-44. PubMed ID: 11976404
[TBL] [Abstract][Full Text] [Related]
37. Inadequate ischaemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischaemia and reperfusion in the rat isolated perfused heart.
Farkas A; Qureshi A; Curtis MJ
Br J Pharmacol; 1999 Sep; 128(1):41-50. PubMed ID: 10498833
[TBL] [Abstract][Full Text] [Related]
38. [Inhibition of induced contraction in the isolated rat mesenteric vascular bed by Ro 40-5967, a novel calcium antagonist].
Sato Y; Watanabe H; Himori N
Nihon Yakurigaku Zasshi; 1995 Mar; 105(3):171-6. PubMed ID: 7721195
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of L- and T-type calcium antagonists on contractions of human detrusor muscle.
Badawi JK; Li H; Langbein S; Kwon ST; Kamp S; Bross S
Eur J Clin Pharmacol; 2006 May; 62(5):347-54. PubMed ID: 16602019
[TBL] [Abstract][Full Text] [Related]
40. In-vitro negative chronotropic and inotropic effects of a novel dihydropyridine derivative, CD-832, in the guinea-pig: comparison with calcium-channel antagonists.
Noguchi K; Takahashi K; Higuchi S
J Pharm Pharmacol; 1998 Mar; 50(3):329-34. PubMed ID: 9600727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
